filmov
tv
Key Takeaway 6: I/O: Combination vs Monotherapy
Показать описание
A discussion on when to use immunotherapy in patients with mCRC and whether I/O combination therapy nivolumab with ipilimumab is a more effective therapy than PD-1 antibody monotherapy.
0:06:25
0:06:54
1:14:31
0:06:26
0:06:09
0:00:31
0:02:05
0:02:36
0:02:45
0:10:00
0:16:28
0:04:40
0:08:30
0:02:30
0:02:26
0:06:28
0:13:46
0:01:01
0:05:35
0:36:44
0:17:14
0:01:46
0:01:59
0:06:30